Golden Door Award 2026 - International Institute of New England

the 44th golden door award

IINE was thrilled to honor Dr. Yvonne Greenstreet, MD, MBA, Chief Executive Officer, Alnylam, with the Golden Door Award.

For more than 50 years, IINE has presented the Golden Door Award annually to a person born outside of the U.S. who has made outstanding contributions to U.S. society.

Wednesday, April 15, 2026
Omni Boston Hotel at the Seaport, 450 Summer St, Boston, MA 02210

Thank you to all who joined us!

Our annual gala is an occasion that calls us to stand together in celebration of the achievements of immigrants who have played an integral role in our communities, economy, and society.

The award takes its name from Emma Lazarus’s words inscribed at the base of the Statue of Liberty: “From her beacon hand glows world-wide welcome… I lift my lamp beside the golden door.”

THE 2026 GOLDEN DOOR AWARD HONOREE

Dr. Yvonne Greenstreet, MD, MBA

Dr. Greenstreet, MD, MBA, OBE, is an esteemed leader with more than 30 years of experience in the biopharmaceutical industry.

Born in London and raised in Ghana and the U.K., she earned a medical degree from the University of Leeds and practiced as a clinician before earning her MBA from INSEAD in France and moving into the biopharmaceutical industry, driven by her ambition to have a greater impact on patients. She moved to the United States in 2004.

Yvonne’s career includes significant senior roles at GlaxoSmithKline plc and Pfizer, where she ran a rapidly growing multi-billion-dollar medicine development division. She joined Alnylam in 2016 as chief operating officer, rising to become president and then, in late 2021, CEO. She has guided Alnylam’s quest to turn the Nobel-Prize-winning science of RNA interference into a new class of medicines and helped to transform the company from a pioneering R&D organization into one of the top biotechnology companies in the world, with a portfolio of medicines available in more than 70 countries and an expanding pipeline of promising medicines in development for both rare and prevalent diseases. Under Yvonne, Alnylam has consistently earned recognition as an exceptional workplace and socially responsible company.

Yvonne serves on the board of directors of The American Funds and the Biomedical Sciences Careers Program and is a member of the Council on Foreign Relations. She was awarded the Order of the British Empire in 2025 for services to the biotechnology and life sciences industry and was recognized in 2024 as the Healthcare Businesswomen’s Association Woman of Year.

Comité d'accueil

Chairs
Anthony Consigli • CEO, Consigli Construction Company
Julie Kim • CEO-elect, Takeda
Graham Robinson • Partner, Kirkland & Ellis, LLP

Members
Noubar Afeyan • Founder and CEO, Flagship Pioneering; Chairman, Moderna
Sapna Tailor Annicelli • Partner, Fragomen
Stéphane Bancel* • CEO, Moderna
David Bartel • Professor of Biology, MIT, HHMI, & Whitehead Institute; Co-Founder, Alnylam
Rainer M. Blair • President and CEO, Danaher Corporation
Josh Boger • President, Boger Family Foundation
Michael Bonney
Marc N. Casper • Chairman and CEO, Thermo Fisher Scientific
Jim Champy • Former Chairman and CEO, CSC Index
Sarah Chapin Columbia • Partner, IP Practice Group, McDermott Will & Schulte LLP
Deborah Dunsire* • Chair, Neurvati Neurosciences
Dr. Victor Dzau* • President, National Academy of Medicine
Larry and Atsuko Fish • Fish Family Foundation
Nicholas Galakatos • Global Head of Blackstone Life Sciences, Blackstone
Marina Hatsopoulos • Board Chair, Levitronix
Jean Hynes • CEO and Managing Partner, Wellington Management
Bill Kane • President – East Coast & UK Markets, BioMed Realty
Adam Koppel • Partner, Bain Capital Life Sciences
Keith Linhart • Partner, CrossCountry Consulting
Olivier LeClerc • Senior Partner, McKinsey & Company
Mark Levin • Working Chair, The Possible Zone
John Maraganore • Co-CEO, Corsera Health
John McQuillan • Chairman and CEO, Triumvirate Environmental, Inc.
Yiannis and Jamie Monovoukas
Amir Nashat • CEO of Souffle Therapeutics
Catherine Pagliarulo • Vice President-Life Science, Alexandria Real Estate Equities, Inc.
Rob Perez • Founder and Chairman, Life Science Cares and BLOC
Paul Schimmel • MacArthur Professor Emeritus, MIT and Professor of Integrative Structural and Computational Biology, Scripps Research; Co-Founder, Alnylam Pharmaceuticals
Gabriel Schmergel* • Retired Biotech CEO
Amy Schulman and David Nachman
Marshall Smith • Chairman of Investment Banking, Goldman Sachs
Phillip Sharp • Institute Professor emeritus, MIT, and Co-Founder, Alnylam
Belinda Termeer** • President, Co-Founder, and Member of the Board of Directors, Termeer Institute
Phillip D. Zamore • Chair, RNA Therapeutics Institute, University of Massachusetts Chan Medical School, and Co-Founder, Alnylam Pharmaceuticals